Update on Executive and Senior Leadership appointment

We are pleased to share the news that Dr Clara Day has been appointed as Executive Medical Director.

Clara is currently the Chief Medical Officer at NHS Birmingham and Solihull and will join the Health Board in September.

Clara was appointed as a consultant kidney doctor at University Hospitals Birmingham (UHB) in 2008, specialising in the care of patients on dialysis. She has long had a particular interest in care of patients with long term health conditions, recognising the need for joined up care across services to ensure best patient and population health outcomes.

As Medical Lead for the Birmingham and Solihull COVID-19 vaccination programme, she led the clinical collaboration required for its successful delivery. These experiences of joined up system working encouraged her into a broader clinical leadership and she was appointed to the role of Chief Medical Officer for Birmingham and Solihull Integrated Care Board in May 2022 . As CMO Clara has had a particular focus on quality, joined up clinical leadership and system-wide clinical pathway transformation in both planned and unplanned care.

Clara also has an interest in clinical stewardship and ensuring best value for the health and care spend, having held the position of Assistant Medical Director for Finance and Value in UHB. She has also held national roles for renal within NHS England, including leading the renal community through the first wave of COVID-19 and setting up the National Renal Transformation Programme. She is a Health Foundation Generation Q fellow and has a PhD in Immunology from the University of Birmingham.

We would also like to thank Dr Sreeman Andole, who has been the Interim Executive Medical Director since December 2024 and will carry on that role until Clara joins us later this year.